Operating Expenses Endring Dato
AbbVie USD 11.11B 540M 2023-12
Abbott USD 8.45B 21M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Baxter International USD 3.59B 173M 2023-12
Bayer EUR 13.94B 1.94B 2023-09
Becton, Dickinson and Co. USD 4.27B 471M 2023-12
Biogen USD 2.03B 344.1M 2023-12
Boston Scientific USD 3.14B 307M 2023-12
Bristol-Myers Squibb USD 9.62B 984M 2023-12
CONMED USD 276.86M 2.58M 2023-12
Cooper Companies USD 791.4M 12.8M 2023-09
Dexcom USD 817.6M 48.1M 2023-12
Edwards Lifesciences USD 1.13B 71.5M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Globus Medical USD 606.41M 223.18M 2023-12
Hologic USD 814.9M 2.1M 2023-12
Insulet USD 403.4M 25.5M 2023-12
Integra LifeSciences USD 361.11M 5.16M 2023-12
Intuitive Surgical USD 1.48B 200.2M 2023-12
J&J USD 16.57B 435M 2023-12
Merck USD 16.56B 6.35B 2023-12
Merit Medical Systems USD 280.09M 11.15M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Stryker USD 4.56B 580M 2023-12
Tandem Diabetes Care USD 231.86M 14.69M 2023-12
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09
Zimmer Biomet Holdings USD 1.59B 98.9M 2023-12
Zoetis USD 1.56B 129M 2023-12



J&J Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.